 |
PDBe Entry: 1ftq 
STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN
 |
TRANSFERASE
|
|
X-RAY DIFFRACTION
|
|
Resolution: 2.35 Å, R-factor: 17.7%, Free R-factor: 22.8%, Spacegroup: P 43 21 2
|
|
04/10/2000, deposition: 13/09/2000, last revision: 24/02/2009
|
Watson, K.A. ; Tsitsanou, K.E. ; Gregoriou, M. ; Zographos, S.E. ; Skamnaki, V.T. ; Oikonomakos, N.G. ; Fleet, G.W. ; Johnson, L.N.
|
Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase. PROTEINS vol:61, pag:966-983 (2005) [PubMed ID 16222658 ]
|
TRANSFERASE , GLYCOGEN PHOSPHORYLASE , INHIBITOR COMPLEX , CATALYTIC SITE , DESIGN
|
2.4.1.1 ExPASy BRENDA (A)
|
Oryctolagus cuniculus(rabbit) 9986 (A)
|
Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase) P00489 (A)
|
|
A
|
|
1b4d, 1ggn, 1fs4, 1ftw, 1fty, 1fu4, 1fu7, 1fu8
|
| A |
GLYCOGEN PHOSPHORYLASE |
Protein |
P00489 (PYGM_RABIT)
|
842 |
98% |
|
| A |
SUGAR (3-AMINO-8,9,10-TRIHYDROXY-7-HYDROXYMETHYL-6-OXA-1,3-DIAZA-SPIRO[4.5]DECANE-2,4-DIONE) |
GL2
 |
| A |
PYRIDOXAL-5'-PHOSPHATE |
PLP
 |
| A |
INOSINIC ACID |
IMP
 |
|
|